Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amgen Inc.

Market Cap 192B 166B 153B 143B 268B 18,222B 272B 1,802B 702B 8,869B 719B 704B 30,709B P/E Ratio 2026 *
23.1x
P/E Ratio 2027 * 21x
Enterprise Value 233B 201B 185B 174B 325B 22,141B 330B 2,189B 854B 10,777B 874B 856B 37,314B EV / Sales 2026 *
6.16x
EV / Sales 2027 * 5.85x
Free-Float
99.78%
Yield 2026 *
2.84%
Yield 2027 * 3%
1 day+0.32%
1 week+1.61%
Current month+5.47%
1 month+5.62%
3 months-3.42%
6 months+11.79%
Current year+8.52%
1 week 337.49
Extreme 337.49
358.46
1 month 320.96
Extreme 320.965
358.46
Current year 318.21
Extreme 318.21
391.29
1 year 267.83
Extreme 267.83
391.29
3 years 218.44
Extreme 218.44
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 67 2019-12-31
Chief Operating Officer 59 2016-07-24
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
05-18Free

Director

665 0.0001%
05-18Free

Director

665 0.0001%
05-18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+1.61%+19.48%+63.42% 192B
-2.41%+0.14%+39.53%+154.43% 1,010B
+1.07%+3.48%+53.75%+50.64% 580B
+1.32%+0.22%+18.35%+65.35% 402B
+0.77%0.00%+19.99%+16.80% 330B
-1.42%-1.44%+45.50%+8.37% 294B
-0.85%-2.86%+22.05%+13.80% 280B
+0.44%+3.48%+24.48%+34.39% 281B
+1.66%+1.20%-44.67%-47.49% 197B
-0.22%-2.76%+12.08%+61.30% 156B
Average -0.28%+0.61%+21.05%+42.10% 372.3B
Weighted average by Cap. -0.78%+0.84%+29.10%+65.96%

Financials

2026 *2027 *
Net sales 37.79B 32.64B 30.08B 28.16B 52.77B 3,592B 53.58B 355B 138B 1,749B 142B 139B 6,054B 38.75B 33.47B 30.84B 28.87B 54.11B 3,683B 54.94B 364B 142B 1,793B 145B 142B 6,208B
Net income 8.26B 7.14B 6.58B 6.16B 11.54B 786B 11.72B 77.67B 30.28B 382B 31.02B 30.36B 1,324B 9.04B 7.81B 7.2B 6.74B 12.62B 859B 12.82B 84.96B 33.13B 418B 33.93B 33.21B 1,448B
Net Debt 41.23B 35.61B 32.82B 30.72B 57.57B 3,919B 58.46B 387B 151B 1,908B 155B 151B 6,605B 35.08B 30.3B 27.92B 26.14B 48.98B 3,335B 49.74B 330B 129B 1,623B 132B 129B 5,620B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-06-12 355.20 $ +0.32% 2,730,230
26-06-11 354.06 $ +4.84% 4,727,125
26-06-10 337.73 $ -1.98% 3,000,395
26-06-09 344.56 $ -0.34% 3,388,246
26-06-08 345.73 $ -1.10% 2,488,219
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
355.20USD
Average target price
352.50USD
Spread / Average Target
-0.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!